2)

in deel 3 wordt tabel 3.1 als volgt gewijzigd: a) de titel van de tweede kolom wordt vervangen door: „Chemische naam”; b) de titel van de voorlaatste kolom wordt vervangen door: „Specifieke concentratiegrenzen, M-factoren en ATE's (*); (*) ATE's voor blootstellingsroutes via de mond en de huid worden uitgedrukt in mg/kg lg, wat milligram per kilogram lichaamsgewicht betekent.”; c) de vermelding voor catalogusnummer 607-414-00-6 wordt geschrapt; d) de vermeldingen voor de catalogusnummers 006-044-00-7, 015-101-00-5, 016-096-00-2, 017-011-00-1, 025-002-00-9, 603-180-00-4, 604-014-00-3, 604-016-00-4, 604-090-00-8, 605-003-00-6, 606-047-009, 607-096-00-9, 607-103-00-5, 607-113-00-X, 607-373-00-4, 613-167-00-5, 613-205-00-0 en 614-001-00-4 worden respectievelijk vervangen door de volgende vermeldingen: Catalogus-nummer Chemische naam EG-nr. CAS-nr. Indeling Etikettering Specifieke concentratiegrenzen, M-factoren en ATE's Opmer-kingen Gevarenklasse en -categorie Gevarenaanduiding Pictogram, signaalwoord Gevarenaanduiding Aanvullende gevarenaanduiding „006-044-00-7 isoproturon (ISO); 3-(4-isopropylfenyl)-1,1-dimethylureum 251-835-4 34123-59-6 Carc. 2 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H373 (bloed) H400 H410 GHS08 GHS09 Wng H351 H373 (bloed) H410 M = 10 M = 10” „015-101-00-5 fosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H-isoïndool-2-yl)methyl]-O,O-dimethyldithiofosfaat; O,O-dimethyl-S-ftaalimidomethyldithiofosfaat 211-987-4 732-11-6 Repr. 2 Acute Tox. 4 Acute Tox. 3 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H332 H301 H370 (zenuwstelsel) H400 H410 GHS08 GHS06 GHS09 Dgr H361f H332 H301 H370 (zenuwstelsel) H410 M = 100 M = 100” „016-096-00-2 thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazine-2-ylcarbamoylsulfamoyl)thiofeen-2-carboxylaat — 79277-27-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100” „017-011-00-1 natriumhypochloriet, oplossing … % actief Cl 231-668-3 7681-52-9 Skin Corr. 1B Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 H314 H318 H400 H410 GHS05 GHS09 Dgr H314 H410 EUH031 M = 10 M = 1 EUH031: C ≥ 5 % B” „025-002-00-9 kaliumpermanganaat 231-760-3 7722-64-7 Ox. Sol. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H272 H361d H302 H400 H410 GHS03 GHS08 GHS07 GHS09 Dgr H272 H361d H302 H410” „603-180-00-4 colecalciferol; cholecalciferol; vitamine D3 200-673-2 67-97-0 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 H330 H310 H300 H372 GHS06 GHS08 Dgr H330 H310 H300 H372 inademing: ATE = 0,05 mg/L (stofdeeltjes of nevels) dermaal: ATE = 50 mg/kg lg oraal: ATE = 35 mg/kg lg STOT RE 1; H372: C ≥ 3 % STOT RE 2; H373: 0,3 % ≤ C < 3 %” „604-014-00-3 chloorcresol; 4-chloor-m-cresol; 4-chloor-3-methylfenol 200-431-6 59-50-7 Acute Tox. 4 Skin Corr. 1C Eye Dam. 1 STOT SE 3 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 3 H302 H314 H318 H335 H317 H400 H412 GHS07 GHS05 GHS09 Dgr H302 H314 H335 H317 H410 M = 1” „604-016-00-4 1,2-dihydroxybenzeen; pyrocatechol 204-427-5 120-80-9 Carc. 1Β Muta. 2 Acute Tox. 3 Acute Tox. 3 Skin Irrit. 2 Eye Irrit. 2 H350 H341 H311 H301 H315 H319 GHS08 GHS06 Dgr H350 H341 H311 H301 H315 H319 oraal: ATE = 300 mg/kg lg dermaal: ATE = 600 mg/kg lg” „604-090-00-8 4-tert-butylfenol 202-679-0 98-54-4 Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 1 H361f H315 H318 H410 GHS08 GHS05 GHS09 Dgr H361f H315 H318 H410 M = 1” „605-003-00-6 aceetaldehyde; ethanal 200-836-8 75-07-0 Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 H224 H350 H341 H335 H319 GHS02 GHS08 GHS07 Dgr H224 H350 H341 H335 H319” „606-047-00-9 2-benzyl-2-dimethylamino-4′-morfolinobutyrofenon 404-360-3 119313-12-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410” „607-096-00-9 maleïnezuuranhydride 203-571-6 108-31-6 Acute Tox. 4 STOT RE 1 Skin Corr. 1B Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1A H302 H372 (luchtwegen) (inademing) H314 H318 H334 H317 GHS07 GHS08 GHS05 Dgr H302 H372 (luchtwegen) (inademing) H314 H334 H317 EUH071 Skin Sens. 1A; H317: C ≥ 0,001 %” „607-103-00-5 barnsteenzuuranhydride 203-570-0 108-30-5 Acute Tox. 4 Skin Corr. 1 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 H302 H314 H318 H334 H317 GHS07 GHS05 GHS08 Dgr H302 H314 H334 H317 EUH071” „607-113-00-X isobutylmethacrylaat 202-613-0 97-86-9 Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Skin Sens. 1B H226 H335 H315 H317 GHS02 GHS07 Wng H226 H335 H315 H317 D” „607-373-00-4 quizalofop-P-tefuryl (ISO); (±)-tetrahydrofurfuryl-(R)-2-[4-(6-chloorchinoxaline-2-yloxy)-fenyloxy]propionaat 414-200-4 200509-41-7 Carc. 2 Repr. 2 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H361fd H302 H373 H400 H410 GHS08 GHS07 GHS09 Wng H351 H361fd H302 H373 H410 M = 1 M = 1” „613-167-00-5 reactiemassa (3:1) van 5-chloor-2-methyl-2H-isothiazool-3-on en 2-methyl-2H-isothiazool-3-on — 55965-84-9 Acute Tox. 2 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H310 H301 H314 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H310 H301 H314 H317 H410 EUH071 Skin Corr. 1C; H314: C ≥ 0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Dam. 1; H318: C ≥ 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1A; H317: C ≥ 0,0015 % M = 100 M = 100 B” „613-205-00-0 propiconazool (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichloorfenyl)-4-propyl-1,3-dioxolaan-2-yl]methyl}-1H-1,2,4-triazool 262-104-4 60207-90-1 Repr. 1B Acute Tox. 4 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H360D H302 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H360D H302 H317 H410 M = 1 M = 1” „614-001-00-4 nicotine (ISO); 3-[(2S)-1-methylpyrrolidine-2-yl]pyridine 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H330 H310 H300 H411 GHS06 GHS09 Dgr H330 H310 H300 H411 inademing: ATE = 0,19 mg/L (stofdeeltjes of nevels) dermaal: ATE = 70 mg/kg lg oraal: ATE = 5 mg/kg lg” e) de volgende vermeldingen worden ingevoegd overeenkomstig de volgorde van de in tabel 3.1 opgenomen vermeldingen: Catalogus-nummer Chemische naam EG-nr. CAS-nr. Indeling Etikettering Specifieke concentratiegrenzen, M-factoren en ATE's Opmer-kingen Gevarenklasse en -categorie Gevarenaan-duiding Pictogram, signaalwoord Gevarenaanduiding Aanvullende gevaren-aanduiding „604-094-00-X iso-eugenol; [1] (E)-2-methoxy-4-(prop-1-enyl)fenol; [2] (Z)-2-methoxy-4-(prop-1-enyl)fenol [3] 202-590-7 [1] 227-678-2 [2] 227-633-7 [3] 97-54-1 [1] 5932-68-3 [2] 5912-86-7 [3] Skin Sens. 1A H317 GHS07 Wng H317 Skin Sens. 1A; H317: C ≥ 0,01 %” „607-724-00-1 2,3,5,6-tetrafluor-4-(methoxymethyl)benzyl-(1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-een-1-yl]cyclopropaancarboxylaat; epsilon-metofluthrin — 240494-71-7 Acute Tox. 4 Acute Tox. 3 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H332 H301 H370 (zenuwstelsel) H373 H400 H410 GHS06 GHS08 GHS09 Dgr H332 H301 H370 (zenuwstelsel) H373 H410 M = 100 M = 100” „607-725-00-7 isopropyl-(2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-diënoaat; S-methopreen — 65733-16-6 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 1” „607-726-00-2 pinoxaden (ISO); 8-(2,6-diëthyl-4-methylfenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepine-9-yl-2,2-dimethylpropionaat — 243973-20-8 Repr. 2 Acute Tox. 4 Acute Tox. 4 Eye Irrit. 2 STOT SE 3 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 3 H361d H332 H302 H319 H335 H317 H400 H412 GHS08 GHS07 GHS09 Wng H361d H332 H302 H319 H335 H317 H410 inademing: ATE = 4,63 mg/L (stofdeeltjes of nevels) oraal: ATE = 500 mg/kg lg M = 1” „607-727-00-8 tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoïndool-2-yl)methyl-2,2-dimethyl-3-(2-methylprop-1-een-1-yl)cyclopropaancarboxylaat 231-711-6 7696-12-0 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (zenuwstelsel) (inademing) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (zenuwstelsel) (inademing) H410 M = 100 M = 100” „607-728-00-3 (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoïndool-2-yl)methyl-(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat 214-619-0 1166-46-7 Carc. 2 Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H371 (zenuwstelsel) (inademing) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H371 (zenuwstelsel) (inademing) H410 M = 100 M = 100” „607-729-00-9 mesosulfuron-methyl (ISO); methyl-2-[(4,6-dimethoxypyrimidine-2-ylcarbamoyl)sulfamoyl]-α-(methaansulfonamido)-p-toluaat; — 208465-21-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 100 M = 100” „607-730-00-4 spirodiclofen (ISO); 3-(2,4-dichloorfenyl)-2-oxo-1-oxaspiro[4.5]dec-3-een-4-yl-2,2-dimethylbutyraat — 148477-71-8 Carc. 1B Repr. 2 STOT RE 2 Skin Sens. 1B Aquatic Chronic 1 H350 H361f H373 H317 H410 GHS08 GHS07 GHS09 Dgr H350 H361f H373 H317 H410 M = 10” „607-731-00-X natrium-methyl-[(4-aminofenyl)sulfonyl]carbamaat; natrium-methyl-(EZ)-sulfanilylcarbonimidaat; asulam-natrium 218-953-8 2302-17-2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 1 M = 1” „607-732-00-5 salicylzuur 200-712-3 69-72-7 Repr. 2 Acute Tox. 4 Eye Dam. 1 H361d H302 H318 GHS08 GHS07 GHS05 Dgr H361d H302 H318” „608-068-00-9 flutianil (ISO); (2Z)-{[2-fluor-5-(trifluormethyl)fenyl]thio}[3-(2-methoxyfenyl)-1,3-thiazolidine-2-ylideen]acetonitril — 958647-10-4 Aquatic Chronic 1 H410 GHS09 Wng H410 M = 100” „612-293-00-8 reactiemassa van 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine en 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine 447-920-2 — Repr. 2 Acute Tox. 4 Skin Corr. 1B Eye Dam. 1 H361f H302 H314 H318 GHS08 GHS07 GHS05 Dgr H361f H302 H314 EUH071” „613-326-00-9 2-methylisothiazool-3(2H)-on 220-239-6 2682-20-4 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H311 H301 H314 H318 H317 H400 H410 GHS05 GHS06 GHS09 Dgr H330 H311 H301 H314 H317 H410 EUH071 Skin Sens. 1A; H317: C ≥ 0,0015 % M = 10 M = 1” „613-327-00-4 pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazool[1,5-a]pyrimidine-2-yl)-2-methoxy-4-(trifluormethyl)pyridine-3-sulfonamide — 422556-08-9 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H317 H400 H410 GHS07 GHS09 Wng H317 H410 M = 100 M = 100” „613-328-00-X 1-vinylimidazool 214-012-0 1072-63-5 Repr. 1B H360D GHS08 Dgr H360D Repr. 1B; H360D: C ≥ 0,03 %” „616-224-00-2 amisulbrom (ISO); 3-3-(broom-6-fluor-2-methylindool-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazool-1-sulfonamide — 348635-87-0 Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H351 H319 H400 H410 GHS08 GHS07 GHS09 Wng H351 H319 H410 M = 10 M = 10”